Clinical Trial

PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 28, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to assess the performance and safety of the AQUABEAM Robotic System for the resection and removal of prostate tissue in patients experiencing lower urinary tract symptoms (LUTS) and are diagnosed with localized prostate cancer. Participants will go through baseline and follow up assessments up to 12 months.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2023-09-18; most recent amendment 2026-01-26.
Status change: Recruiting → Active, Not Recruiting 2026-01-26
Trial Details
NCT Number NCT06051942
Lead Sponsor PROCEPT BioRobotics
Conditions Benign Prostatic Hyperplasia, Localized Prostate Cancer
Enrollment 125 participants
Start Date 2022-11-22
Primary Completion 2026-07 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-01-28